EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension

Jan Zeman, Crystal Kamilaris

Prague Medical Report · 2025

DOI: 10.14712/23362936.2025.23 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Prague Medical Report, 2025. Verfasst von Jan Zeman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Connecticut, Farmington, Connecticut, USA. jan.zeman94@gmail.com. Hauptthemen laut MEDLINE: Hyperaldosteronism, Hypertension, Intracranial Aneurysm, Glucocorticoids. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoid remediable aldosteronism (GRA) also known as familial hyperaldosteronism type 1 (FH1) is a rare genetic form of primary aldosteronism characterized by aldosterone overproduction regulated by adrenocorticotropic hormone (ACTH). We present the case of a 54-year-old woman with severe hypertension and hypokalemia. Genetic testing confirmed GRA by identifying a chimeric gene involving CYP11B1 and CYP11B2. This case highlights the importance of considering GRA in patients with resistant hypertension and a family history of cerebral aneurysms. Management involved glucocorticoid therapy and mineralocorticoid receptor antagonists, leading to significant improvement in blood pressure control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperaldosteronismHypertensionIntracranial AneurysmGlucocorticoidsHumansFemaleMiddle AgedSteroid 11-beta-HydroxylaseMineralocorticoid Receptor AntagonistsCytochrome P-450 CYP11B2

Stichwörter der Autor:innen

Cerebral aneurysmFamilial hyperaldosteronism type 1Genetic testingGlucocorticoid remediable aldosteronismHypertensionMineralocorticoid receptor antagonistPrimary aldosteronism

Substanzen

GlucocorticoidsSteroid 11-beta-HydroxylaseMineralocorticoid Receptor AntagonistsCytochrome P-450 CYP11B2

Autor:innen und Institutionen

  • Department of Medicine, University of Connecticut, Farmington, Connecticut, USA. jan.zeman94@gmail.com.
  • Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. jan.zeman94@gmail.com.
  • Department of Endocrinology, NIH, Maryland, USA.

Zitieren

APA

Zeman, J., & Kamilaris, C. (2025). Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension. Prague Medical Report. https://doi.org/10.14712/23362936.2025.23

Vancouver

Zeman J, Kamilaris C. Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension. Prague Medical Report. 2025. doi:10.14712/23362936.2025.23

BibTeX
@article{Zeman2025,
  author = {Zeman, Jan and Kamilaris, Crystal},
  title = {Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension},
  journal = {Prague Medical Report},
  year = {2025},
  doi = {10.14712/23362936.2025.23}
}
Kostenlos starten →